2007, Chemotherapy and Vaccines - Pharmacy Technician Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2007

Chemotherapy

Vaccines

NK cell immunotherapy: what’s next in clinical development?

European Pharmaceutical Review

DECEMBER 12, 2023

IPH5201 is being investigated in a Phase II trial, MATISSE, in combination with durvalumab (anti-PD-L1) and chemotherapy, in patients with resectable early-stage NSCLC. In 2007, he became in charge for business development and in 2017, also became responsible of the portfolio strategy.

Immunization

Immunization Chemotherapy Pharmaceutical Companies Pharmaceutical Companies

Beating the Big C

Pharmaceutical Technology

JULY 23, 2008

Demand for treatment The American Cancer Society estimates that over 12 million new cancer cases were diagnosed worldwide in 2007. “You can get vaccines now to prevent cervical cancer. And are we getting any closer to beating the Big C? “For certain cancers, yes,” says Ando.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Compounding Chemotherapy

NK cell immunotherapy: what’s next in clinical development?

Beating the Big C

Stay Connected